The same active ingredient as Ozempic® and Wegovy®. Clinically proven to reduce body weight by 15–22%.[1] Supervised by board-certified providers at our Miami office.
✅ Great news! We ship directly to California — Start your program today
Professional medical weight loss from Miami to your doorstep
Start your semaglutide program from anywhere in the US. Our board-certified Miami physicians provide telehealth consultations and prescribe compounded semaglutide with temperature-controlled shipping to ensure medication potency. Includes Alaska, Hawaii, and Puerto Rico.
Semaglutide is a GLP-1 receptor agonist — it mimics a hormone your body naturally produces after eating. The result: you feel satisfied sooner, eat less without feeling deprived, and your blood sugar stays stable.[2]
Reduces hunger and cravings at the neurological level — not willpower, science.
Food stays in your stomach longer, so you feel full for hours after eating.
Helps your pancreas release insulin appropriately, reducing fat storage.
Unlike crash diets, the changes you make on semaglutide tend to stick.
Unlike other clinics that use shared compound vials with questionable storage and expiration dates, we provide individual vials sized for your exact needs. Here's how our pricing works and why it matters.
Quality, consistency, and safety you can trust — every single dose.
Weekly dose (starting at 0.25mg) ÷ vial size = number of doses per vial.Vial cost ÷ number of doses = cost per dose. Cost per dose × 4 weeks = monthly cost.
Semaglutide requires gradual dose escalation for safety — starting at 0.25mg weekly and increasing every 4 weeks as tolerated. We help you choose the most cost-effective vial size for your prescribed dosing schedule.
Only the 4 vial sizes above are available. We'll recommend the most cost-effective option for your prescribed dose.
Semaglutide requires gradual dose escalation for safety and tolerability. You start at 0.25mg weekly and increase every 4 weeks as tolerated. Our board-certified providers determine your optimal dose based on your response and medical history. This isn't like ordering from a menu — it's personalized medical treatment.
Semaglutide's efficacy is supported by multiple large-scale, peer-reviewed studies published in leading medical journals.
N Engl J Med, 2021
1,961 adults with obesity received once-weekly semaglutide 2.4 mg or placebo for 68 weeks. Results: 14.9% mean body weight reduction vs 2.4% with placebo.
View on PubMedLancet, 2021
1,210 adults with overweight/obesity and type 2 diabetes. Semaglutide 2.4 mg achieved 9.6% weight loss and significant HbA1c reduction vs placebo.
View on PubMedNat Med, 2022
Two-year study of 304 adults. Semaglutide produced 15.2% mean weight loss at 104 weeks, demonstrating sustained long-term efficacy.
View on PubMedJAMA, 2021
Weight loss maintenance study. Participants who continued semaglutide maintained 17.4% total weight loss vs 5.6% regain in placebo group.
View on PubMedSemaglutide improves your overall metabolic health — not just the number on the scale.
Reduced risk of major cardiac events, improved blood pressure and cholesterol.
Better insulin sensitivity — beneficial for prediabetes and type 2 diabetes.
Significantly fewer food cravings and emotional eating episodes.
As weight drops and metabolism improves, energy levels rise noticeably.
Achieving your goals naturally boosts self-esteem and quality of life.
Sustainable approach with ongoing support to maintain your results.
Low starting dose. Most patients notice reduced appetite within the first week. Initial weight loss of 2–5 lbs as eating patterns shift.
Dose increases to therapeutic levels. Weight loss accelerates — typically 1–2 lbs/week. Energy improves. Results become visible.
Maintenance dose. Consistent weight loss continues. Most patients have lost 10–15% of starting weight. New habits feel natural.
Continue to reach your goal. Many achieve 15–22% total body weight loss. Focus shifts to long-term maintenance.
Clinical trials show an average of 15–22% total body weight loss over 68 weeks. Most patients see noticeable results within the first 4–8 weeks.
Mild nausea is the most common side effect, especially in the first few weeks. Starting at a low dose and gradually increasing minimizes this. Most patients find it manageable and temporary.
Once-weekly subcutaneous injection — typically in the abdomen, thigh, or upper arm. We train you on self-injection, or you can come in weekly. It takes seconds.
Semaglutide is FDA-approved for adults with a BMI of 30+, or 27+ with a weight-related condition. We'll review your health history during your free consultation.
We work with you on a transition plan. The healthy habits you build during treatment — portion awareness, food choices — help maintain results long-term.
We're transparent about pricing — no hidden fees. Call us or book a free consultation and we'll walk you through everything upfront.
Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
PubMedDavies M, et al. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397(10278):971-984.
PubMedGarvey WT, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28(10):2083-2091.
PubMedRubino D, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414-1425.
PubMedFree consultation. No commitment. A real Miami doctor answers your questions.
Explore other treatments